FMC stock steadies as shares hold near 52-week range
Published on 08/30/2026 at 16:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
FMC stock (ISIN DE0005785802) is trading at EUR 39.920 on Xetra, with the share price sitting between a 52-week low of EUR 34.570 and a 52-week high of EUR 47.860 as of August 29, 2026. The latest reported quarter showed revenue of EUR 4.79 billion and operating income of EUR 315 million, giving investors a current read on the scale of the dialysis business.
Latest quarter in view
Fresenius Medical Care reported revenue of EUR 4.79 billion and operating income of EUR 315 million in the most recent quarter, figures that frame the stock's current valuation debate. Revenue and profit remain the key anchors because the company operates in a high-volume, high-cost care model.
That quarter also matters because it sets the comparison base for the next update, and the operating result shows how much of the sales line survives into earnings. For a healthcare provider with a large recurring treatment base, that conversion ratio often matters more than headline growth.
Price level and comparison
At EUR 39.920, the shares trade EUR 7.940 below the 52-week high and EUR 5.350 above the 52-week low. That gives the market a clear range to work with as investors weigh whether the stock is pricing in a stable earnings path or a slower recovery.
The quantified comparison is straightforward: the current quote is 16.8 percent below the 52-week high of EUR 47.860. A move of that size keeps the chart honest and leaves room for both upside and caution.
Business lens
Fresenius Medical Care's core business remains dialysis care and related products, including treatment equipment, consumables, and services for patients with kidney failure. That mix matters because recurring treatment demand can soften swings in individual product cycles.
The product side also gives the company a broader footprint than a pure hospital operator, since equipment and consumables support the service network. For investors, that combination is what makes the quarterly operating result more important than a single product headline.
Stock level to watch
FMC shares closed at EUR 39.920 on August 29, 2026, and the current level keeps them closer to the middle of the 52-week band than to either extreme. That makes the next earnings read and margin trend more relevant than a short-lived price spike.
More on Fresenius Medical Care stock
Company: Fresenius Medical Care AG
ISIN: DE0005785802
Ticker: FME
Exchange: Xetra
Market cap: EUR 10.58 billion as of August 29, 2026
Sector / Industry: Health Care / Health Care Providers & Services
Index membership: MDAX
